Literature DB >> 17531588

Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study).

Avni H Thakore1, Chao-Yu Guo, Martin G Larson, Diane Corey, Thomas J Wang, Ramachandran S Vasan, Ralph B D'Agostino, Izabella Lipinska, John F Keaney, Emelia J Benjamin, Christopher J O'Donnell.   

Abstract

Inflammatory markers, particularly C-reactive protein (CRP), predict incident cardiovascular disease and are associated with the presence of subclinical atherosclerosis. The relations between multiple inflammatory markers and direct measures of atherosclerosis are less well established. Participants in the Offspring Cohort of the Framingham Heart Study (n = 2,885, 53% women, mean age 59 years) received routine assessments of common carotid artery intima-media thickness (CCA-IMT), internal carotid artery intima-media thickness (ICA-IMT), and the presence or absence of > or =25% carotid stenosis by ultrasonography. Circulating inflammatory markers assessed from an examination 4 years later included CRP, interleukin-6 (IL-6), intercellular adhesion molecule-1, monocyte chemoattractant protein-1, P-selectin, and CD40 ligand. Assessed as a group, inflammatory markers were significantly associated with ICA-IMT (p = 0.01), marginally with carotid stenosis (p = 0.08), but not with CCA-IMT. Individually, with an increase from the 25th to 75th percentile in IL-6, there were significant increases in ICA-IMT and carotid stenosis (for ICA-IMT, estimated fold increase 1.04, 95% confidence interval 1.03 to 1.06, p = 0.0004; for carotid stenosis, odds ratio 1.25, 95% confidence interval 1.06 to 1.47, p = 0.007) after adjustment for age, gender, and established risk factors for atherosclerosis. There was a similar significant multivariate-adjusted association of CRP with ICA-IMT but not with carotid stenosis. Smoking appeared to modify the associations of ICA-IMT with CRP (p = 0.009) and with IL-6 (p = 0.006); the association was more pronounced in current (vs former or never) smokers. In conclusion, there were modest associations of inflammatory markers, particularly IL-6, with carotid atherosclerosis. This association appears more pronounced in current smokers than in former smokers and nonsmokers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531588     DOI: 10.1016/j.amjcard.2007.01.036

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  40 in total

Review 1.  The role of carotid intimal thickness and plaque imaging in risk stratification for coronary heart disease.

Authors:  Smita I Negi; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

2.  Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response.

Authors:  Eric Frisdal; Philippe Lesnik; Maryline Olivier; Paul Robillard; M John Chapman; Thierry Huby; Maryse Guerin; Wilfried Le Goff
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

Review 3.  Intersection between gonadal function and vascular aging in women.

Authors:  Kerrie L Moreau
Journal:  J Appl Physiol (1985)       Date:  2018-09-13

4.  Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study.

Authors:  Ann B Nguyen; Anand Rohatgi; Christine K Garcia; Colby R Ayers; Sandeep R Das; Susan G Lakoski; Jarett D Berry; Amit Khera; Darren K McGuire; James A de Lemos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-04       Impact factor: 8.311

5.  Metabolic syndrome showed significant relationship with carotid atherosclerosis.

Authors:  Tomoyuki Kawada; Takeshi Andou; Masayuki Fukumitsu
Journal:  Heart Vessels       Date:  2015-03-26       Impact factor: 2.037

Review 6.  The macrophage: the intersection between HIV infection and atherosclerosis.

Authors:  Suzanne M Crowe; Clare L V Westhorpe; Nigora Mukhamedova; Anthony Jaworowski; Dmitri Sviridov; Michael Bukrinsky
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

7.  Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.

Authors:  Allison C Ross; Nesrine Rizk; Mary Ann O'Riordan; Vikram Dogra; Dalia El-Bejjani; Norma Storer; Danielle Harrill; Marisa Tungsiripat; Jerome Adell; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2009-10-01       Impact factor: 9.079

8.  Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection.

Authors:  Renate Schnabel; Martin G Larson; Josée Dupuis; Kathryn L Lunetta; Izabella Lipinska; James B Meigs; Xiaoyan Yin; Jian Rong; Joseph A Vita; Christopher Newton-Cheh; Daniel Levy; John F Keaney; Ramachandran S Vasan; Gary F Mitchell; Emelia J Benjamin
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

9.  The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.

Authors:  Jessica M Bon; Joseph K Leader; Joel L Weissfeld; Harvey O Coxson; Bin Zheng; Robert A Branch; Venkateswarlu Kondragunta; Janet S Lee; Yingze Zhang; Augustine M K Choi; Anna E Lokshin; Naftali Kaminski; David Gur; Frank C Sciurba
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.